Duchenne-izomdisztrófia: vizsgálatok itt: Szerbia
2 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in SzerbiaEfficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
- Where
- Belgrade
- Életkor
- 9 év to 17 év
- People
- 138 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT05933057 · EU 2023-503521-19-00 - 2/3. fázisCsak meghívásosGivinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- Where
- Belgrade
- Életkor
- 7 év and over
- People
- 206 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT03373968